Arecor Therapeutics (AREC) Share Price, News & Analysis

Company Overview

Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products. The Arestat™ platform is supported by an extensive patent portfolio. For further details please see our website, www.arecor.com

Key Stats

• Today's Range: 50 to 52
• 50-Day Range: 50 to 75
• 52-Week Range: 50 to 170
• Volume: 3,900 shs
• Average Volume: 5,931 shs
• Market Capitalization: £19.63 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AREC Stock Analysis - Frequently Asked Questions

How have AREC shares performed this year?

Arecor Therapeutics' stock was trading at GBX 73.75 at the beginning of the year. Since then, AREC stock has decreased by 29.5% and is now trading at GBX 52.
View the best growth stocks for 2025 here.

How do I buy shares of Arecor Therapeutics?

Shares of AREC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Arecor Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Arecor Therapeutics investors own include Pfizer (PFE), NVIDIA (NVDA), PayPal (PYPL), Advanced Micro Devices (AMD), Cisco Systems (CSCO), Lowe's Companies (LOW) and SNDL (SNDL).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Coal
• Current Symbol: LON:AREC
• CUSIP: N/A
• CIK: N/A
• Web: www.americanresourcescorp.com
• Phone: 44 1223 426 060
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (28.30)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £-10,683,346.07
• Net Margins: -176.89%
• Pretax Margin: N/A
• Return on Equity: -118.67%
• Return on Assets: -37.31%

Debt

• Debt-to-Equity Ratio: 5.51
• Current Ratio: 1.37
• Quick Ratio: 6.24

Sales & Book Value

• Annual Sales: £6.04 million
• Price / Sales: 3.25
• Cash Flow: GBX 10.25 per share
• Price / Cash Flow: 5.07
• Book Value: GBX 16.58 per share
• Price / Book: 3.14

Miscellaneous

• Outstanding Shares: 37,756,599
• Free Float: N/A
• Market Cap: £19.63 million
• Optionable: Not Optionable
• Beta: -0.18